Literature DB >> 14693839

Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population.

K S Cuschieri1, H A Cubie, M W Whitley, A L Seagar, M J Arends, C Moore, G Gilkisson, E McGoogan.   

Abstract

AIMS: If human papillomavirus (HPV) testing is to be included within cervical screening programmes, the importance of multiple HPV infections in cervical neoplasia needs to be determined. This study investigated the diversity of multiple HPV types in a routine cervical screening population, and assessed associations with cervical neoplasia.
METHODS: Overall HPV prevalence, type specific prevalence, and extent of multiple infection were assessed in residual material from 3444 liquid based cytology samples, using real time GP5+/GP6+ polymerase chain reaction for screening and linear array assay for genotyping. HPV status was studied in relation to age and concurrent cytological evidence of dyskaryosis.
RESULTS: Twenty per cent of samples were HPV positive. HPV type diversity was broad, and multiple HPV infections occurred in half of the HPV positive samples. Younger women were significantly more likely to harbour multiple high risk HPV (HR-HPV) infections. Infections with multiple HR-HPV types were found in 3.4% of samples negative for neoplasia and in 33.3%, 41.8%, and 40.4% of samples with borderline, mild, or high grade dyskaryosis, respectively. Single HR-HPV infections were found in 4.9%, 38.6%, 45.0%, and 51.1% of negative, borderline, mild, or high grade dyskaryosis samples, respectively.
CONCLUSIONS: Multiple HR-HPV infections were most prevalent in young women. Multiple HR-HPV infections were not more frequent in high grade than in low grade cervical neoplasia, reflecting common sexual transmission of multiple HR-HPV. Prospective cohort studies linking sequential loss or gain of HPV types with cytological analysis are required to assess the impact of multiple HR-HPV infections on neoplastic progression.

Entities:  

Mesh:

Year:  2004        PMID: 14693839      PMCID: PMC1770158          DOI: 10.1136/jcp.57.1.68

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  23 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Concurrent and sequential acquisition of different genital human papillomavirus types.

Authors:  K K Thomas; J P Hughes; J M Kuypers; N B Kiviat; S K Lee; D E Adam; L A Koutsky
Journal:  J Infect Dis       Date:  2000-09-05       Impact factor: 5.226

3.  Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group.

Authors: 
Journal:  J Natl Cancer Inst       Date:  2000-03-01       Impact factor: 13.506

4.  Determinants of cervical human papillomavirus infection: differences between high- and low-oncogenic risk types.

Authors:  Paul K S Chan; Alexander R Chang; Jo L K Cheung; Denise P C Chan; L Y Xu; Nelson L S Tang; Augustine F Cheng
Journal:  J Infect Dis       Date:  2001-12-05       Impact factor: 5.226

5.  Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia.

Authors:  K H Fife; H M Cramer; J M Schroeder; D R Brown
Journal:  J Med Virol       Date:  2001-08       Impact factor: 2.327

6.  Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection.

Authors:  M C Rousseau; J S Pereira; J C Prado; L L Villa; T E Rohan; E L Franco
Journal:  J Infect Dis       Date:  2001-12-03       Impact factor: 5.226

7.  Rapid real time PCR to distinguish between high risk human papillomavirus types 16 and 18.

Authors:  H A Cubie; A L Seagar; E McGoogan; J Whitehead; A Brass; M J Arends; M W Whitley
Journal:  Mol Pathol       Date:  2001-02

8.  Human papillomavirus infection and invasive cervical cancer in Paraguay.

Authors:  P A Rolón; J S Smith; N Muñoz; S J Klug; R Herrero; X Bosch; F Llamosas; C J Meijer; J M Walboomers
Journal:  Int J Cancer       Date:  2000-02-15       Impact factor: 7.396

9.  Determinants of genital human papillomavirus detection in a US population.

Authors:  C L Peyton; P E Gravitt; W C Hunt; R S Hundley; M Zhao; R J Apple; C M Wheeler
Journal:  J Infect Dis       Date:  2001-05-09       Impact factor: 5.226

10.  HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.

Authors:  G D Zielinski; P J Snijders; L Rozendaal; F J Voorhorst; H C van der Linden; A P Runsink; F A de Schipper; C J Meijer
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

View more
  68 in total

1.  HPV73 a nonvaccine type causes cervical cancer.

Authors:  Sergio M Amaro-Filho; Ana Gradissimo; Mykhaylo Usyk; Fabio C B Moreira; Liz M de Almeida; Miguel A M Moreira; Robert D Burk
Journal:  Int J Cancer       Date:  2019-04-29       Impact factor: 7.396

2.  Data are still needed for HPV immunisation programme.

Authors:  O Noel Gill; Catherine M Lowndes
Journal:  BMJ       Date:  2005-11-19

3.  Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age.

Authors:  Carolyn E Banister; Amy R Messersmith; Bo Cai; Lisa B Spiryda; Saundra H Glover; Lucia Pirisi; Kim E Creek
Journal:  J Infect Dis       Date:  2014-07-15       Impact factor: 5.226

4.  Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adenocarcinoma.

Authors:  Eduardo Cambruzzi; Cláudio Galleano Zettler; Cláudio Osmar Pereira Alexandre
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

5.  Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance.

Authors:  Manola Comar; Michelle R Iannacone; Giorgia Casalicchio; Sandrine McKay-Chopin; Massimo Tommasino; Tarik Gheit
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

6.  Optimizing technology for cervical cancer screening in high-resource settings.

Authors:  Lyndsay A Richardson; Joseph Tota; Eduardo L Franco
Journal:  Expert Rev Obstet Gynecol       Date:  2011-05

7.  Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18-24: results at recruitment.

Authors:  Massimo Confortini; Francesca Carozzi; Marco Zappa; Leonardo Ventura; Anna Iossa; Paola Cariaggi; Livia Brandigi; Mario Franchini; Francesco Mirri; Paolo Viacava; Aurora Scarfantoni; Daniela Bazzanti; Cristina Sani
Journal:  BMC Infect Dis       Date:  2010-06-07       Impact factor: 3.090

8.  Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities.

Authors:  Markus Schmitt; Christophe Depuydt; Ina Benoy; Johannes Bogers; Jerome Antoine; Marc Arbyn; Michael Pawlita
Journal:  J Clin Microbiol       Date:  2013-02-27       Impact factor: 5.948

9.  Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions.

Authors:  S Brismar-Wendel; M Froberg; A Hjerpe; S Andersson; B Johansson
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

10.  Human papillomavirus infection in Honduran women with normal cytology.

Authors:  N Tábora; J M J E Bakkers; W G V Quint; L F A G Massuger; J A Matute; W J G Melchers; A Ferrera
Journal:  Cancer Causes Control       Date:  2009-08-15       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.